

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.15352507 |
| 2 | muscle filament sliding (GO:0030049) | 8.98708225 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.98708225 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.74837382 |
| 5 | cardiac myofibril assembly (GO:0055003) | 7.72530621 |
| 6 | myofibril assembly (GO:0030239) | 7.69080860 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.41675746 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.36856473 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.09179683 |
| 10 | plasma membrane repair (GO:0001778) | 7.06505896 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.71507879 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.54720366 |
| 13 | skeletal muscle fiber development (GO:0048741) | 6.53914489 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.47047544 |
| 15 | cardiac muscle contraction (GO:0060048) | 6.33032739 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 6.03901139 |
| 17 | striated muscle contraction (GO:0006941) | 5.96272202 |
| 18 | cardiac muscle cell development (GO:0055013) | 5.89922595 |
| 19 | skeletal muscle contraction (GO:0003009) | 5.89456605 |
| 20 | myotube cell development (GO:0014904) | 5.88238324 |
| 21 | actomyosin structure organization (GO:0031032) | 5.83943355 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 5.81880795 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 5.75186031 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.68040073 |
| 25 | actin filament-based movement (GO:0030048) | 5.55532122 |
| 26 | cardiac cell development (GO:0055006) | 5.53235361 |
| 27 | carnitine shuttle (GO:0006853) | 5.51114589 |
| 28 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.48756610 |
| 29 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.46179197 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.37451333 |
| 31 | regulation of cell communication by electrical coupling (GO:0010649) | 5.36872515 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.26942059 |
| 33 | muscle cell fate commitment (GO:0042693) | 5.18383437 |
| 34 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.08924766 |
| 35 | skeletal muscle tissue development (GO:0007519) | 5.05844109 |
| 36 | adult heart development (GO:0007512) | 5.02822620 |
| 37 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.99554050 |
| 38 | cardiac muscle hypertrophy (GO:0003300) | 4.98159167 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.96615636 |
| 40 | positive regulation of myotube differentiation (GO:0010831) | 4.93398839 |
| 41 | muscle cell cellular homeostasis (GO:0046716) | 4.93254920 |
| 42 | heart process (GO:0003015) | 4.85372896 |
| 43 | heart contraction (GO:0060047) | 4.85372896 |
| 44 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.83464308 |
| 45 | striated muscle hypertrophy (GO:0014897) | 4.82211374 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 4.80504001 |
| 47 | creatine metabolic process (GO:0006600) | 4.73882134 |
| 48 | skeletal muscle adaptation (GO:0043501) | 4.73611366 |
| 49 | muscle tissue morphogenesis (GO:0060415) | 4.72220021 |
| 50 | fatty acid transmembrane transport (GO:1902001) | 4.70031405 |
| 51 | regulation of sarcomere organization (GO:0060297) | 4.69163805 |
| 52 | heart trabecula formation (GO:0060347) | 4.66355592 |
| 53 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.64640697 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.51605271 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.51605271 |
| 56 | glycogen biosynthetic process (GO:0005978) | 4.45821739 |
| 57 | glucan biosynthetic process (GO:0009250) | 4.45821739 |
| 58 | skeletal muscle tissue regeneration (GO:0043403) | 4.44251812 |
| 59 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.42811526 |
| 60 | response to inactivity (GO:0014854) | 4.38767366 |
| 61 | regulation of membrane repolarization (GO:0060306) | 4.31157511 |
| 62 | muscle hypertrophy (GO:0014896) | 4.25573251 |
| 63 | * muscle contraction (GO:0006936) | 4.24575723 |
| 64 | muscle atrophy (GO:0014889) | 4.20591059 |
| 65 | myoblast fusion (GO:0007520) | 4.20052002 |
| 66 | carnitine transmembrane transport (GO:1902603) | 4.14298437 |
| 67 | striated muscle adaptation (GO:0014888) | 4.12695230 |
| 68 | * muscle organ development (GO:0007517) | 4.07188892 |
| 69 | cellular polysaccharide catabolic process (GO:0044247) | 4.07179795 |
| 70 | * muscle structure development (GO:0061061) | 4.04853385 |
| 71 | striated muscle cell development (GO:0055002) | 3.95952521 |
| 72 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.95101290 |
| 73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.92422347 |
| 74 | * muscle system process (GO:0003012) | 3.92313937 |
| 75 | regulation of the force of heart contraction (GO:0002026) | 3.92302687 |
| 76 | striated muscle atrophy (GO:0014891) | 3.87014705 |
| 77 | NADH metabolic process (GO:0006734) | 3.85350295 |
| 78 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.85055120 |
| 79 | muscle hypertrophy in response to stress (GO:0003299) | 3.85055120 |
| 80 | cardiac muscle adaptation (GO:0014887) | 3.85055120 |
| 81 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.81044021 |
| 82 | positive regulation of myoblast differentiation (GO:0045663) | 3.80095993 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.78615235 |
| 84 | amino-acid betaine transport (GO:0015838) | 3.77692634 |
| 85 | carnitine transport (GO:0015879) | 3.77692634 |
| 86 | response to muscle activity (GO:0014850) | 3.76259237 |
| 87 | glycogen catabolic process (GO:0005980) | 3.73518213 |
| 88 | regulation of sequestering of triglyceride (GO:0010889) | 3.72513322 |
| 89 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.67765629 |
| 90 | cell communication involved in cardiac conduction (GO:0086065) | 3.67713320 |
| 91 | polysaccharide catabolic process (GO:0000272) | 3.66240082 |
| 92 | regulation of sulfur metabolic process (GO:0042762) | 3.65338167 |
| 93 | respiratory electron transport chain (GO:0022904) | 3.64650231 |
| 94 | regulation of myoblast differentiation (GO:0045661) | 3.63125978 |
| 95 | ATP synthesis coupled proton transport (GO:0015986) | 3.62292942 |
| 96 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.62292942 |
| 97 | regulation of ATPase activity (GO:0043462) | 3.61964203 |
| 98 | regulation of ATP catabolic process (GO:1903289) | 3.61964203 |
| 99 | negative regulation of protein localization to cell surface (GO:2000009) | 3.61942807 |
| 100 | muscle fiber development (GO:0048747) | 3.59251854 |
| 101 | response to activity (GO:0014823) | 3.58753835 |
| 102 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.58706606 |
| 103 | negative regulation of potassium ion transport (GO:0043267) | 3.58228766 |
| 104 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.57292852 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.57292852 |
| 106 | striated muscle tissue development (GO:0014706) | 3.57091192 |
| 107 | oxidative phosphorylation (GO:0006119) | 3.56457091 |
| 108 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.55762634 |
| 109 | regulation of cardiac muscle contraction (GO:0055117) | 3.54173077 |
| 110 | electron transport chain (GO:0022900) | 3.53459203 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 3.52931365 |
| 112 | regulation of heart rate (GO:0002027) | 3.50778701 |
| 113 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.50229374 |
| 114 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.48356454 |
| 115 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.48356454 |
| 116 | glucan catabolic process (GO:0009251) | 3.48083278 |
| 117 | cardiac muscle cell action potential (GO:0086001) | 3.47832831 |
| 118 | regulation of muscle system process (GO:0090257) | 3.45960626 |
| 119 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.45423881 |
| 120 | muscle adaptation (GO:0043500) | 3.43969286 |
| 121 | myotube differentiation (GO:0014902) | 3.43173766 |
| 122 | glycogen metabolic process (GO:0005977) | 3.42830890 |
| 123 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.42426080 |
| 124 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.41433191 |
| 125 | muscle organ morphogenesis (GO:0048644) | 3.40401524 |
| 126 | regulation of muscle contraction (GO:0006937) | 3.40166669 |
| 127 | muscle cell development (GO:0055001) | 3.39790792 |
| 128 | positive regulation of heart rate (GO:0010460) | 3.36444403 |
| 129 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.36320297 |
| 130 | glucan metabolic process (GO:0044042) | 3.35754172 |
| 131 | cellular glucan metabolic process (GO:0006073) | 3.35754172 |
| 132 | gluconeogenesis (GO:0006094) | 3.31178250 |
| 133 | regulation of myotube differentiation (GO:0010830) | 3.28709746 |
| 134 | fructose metabolic process (GO:0006000) | 3.22512627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.27709290 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.20992222 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.20464671 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.01060686 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.97427608 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.97427608 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55151842 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.38833289 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.11324195 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.06420019 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.95434183 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.90430941 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45645774 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24838163 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.20349594 |
| 16 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.19398017 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10690504 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06841473 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.82124729 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81717547 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81452346 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.78092997 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75122394 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.72980542 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72685423 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70745275 |
| 27 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.60467958 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60094642 |
| 29 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.59066567 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45883470 |
| 31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44880444 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41893653 |
| 33 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.40188624 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36854327 |
| 35 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.35869107 |
| 36 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33658485 |
| 37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32252309 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31049494 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30798229 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30046481 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28721137 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26649388 |
| 43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24318752 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23998404 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20478944 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18747651 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15255568 |
| 48 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.15222190 |
| 49 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14627686 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13919537 |
| 51 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.12402125 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12374939 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11472839 |
| 54 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11174060 |
| 55 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08486035 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07964587 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07904710 |
| 58 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07688145 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07462786 |
| 60 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05917595 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.05799661 |
| 62 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04770405 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04637563 |
| 64 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.04000153 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03762830 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03523058 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03142045 |
| 68 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01085153 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00778725 |
| 70 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.99359507 |
| 71 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99287753 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99006420 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97986230 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97925986 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96824832 |
| 76 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96528517 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95881306 |
| 78 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95601794 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95460599 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95446904 |
| 81 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95091685 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95044158 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94588138 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94298065 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93819266 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93606252 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92813901 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92716618 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92073576 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91863336 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91147380 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90988486 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89904833 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89756535 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89261949 |
| 96 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89070240 |
| 97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88774595 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88439193 |
| 99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87612855 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87587789 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86385299 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85868030 |
| 103 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85292338 |
| 104 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85114411 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84611426 |
| 106 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84081972 |
| 107 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84081972 |
| 108 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83737824 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83430804 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83381965 |
| 111 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83009388 |
| 112 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82927918 |
| 113 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81575250 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81196503 |
| 115 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81190169 |
| 116 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80991670 |
| 117 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80293561 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80032614 |
| 119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79630865 |
| 120 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79549589 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79486267 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79476642 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79400837 |
| 124 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79361026 |
| 125 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79335710 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79067714 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79067714 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78341698 |
| 129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78301313 |
| 130 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77923098 |
| 131 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77640167 |
| 132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76094397 |
| 133 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76014436 |
| 134 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.75731333 |
| 135 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75582178 |
| 136 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75505039 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73323204 |
| 138 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.72809861 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.72640733 |
| 140 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.72438821 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.71412406 |
| 142 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.70965377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.57267981 |
| 2 | MP0003646_muscle_fatigue | 6.30570800 |
| 3 | MP0000751_myopathy | 5.68775380 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.88992173 |
| 5 | MP0000749_muscle_degeneration | 4.84873479 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.35793363 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.08143370 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.81739741 |
| 9 | MP0005330_cardiomyopathy | 3.56306544 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.37612026 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.16286921 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.15019406 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.91675147 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.80484854 |
| 15 | MP0000747_muscle_weakness | 2.77718150 |
| 16 | MP0004130_abnormal_muscle_cell | 2.76649659 |
| 17 | * MP0002269_muscular_atrophy | 2.60626401 |
| 18 | * MP0000759_abnormal_skeletal_muscle | 2.55838964 |
| 19 | * MP0005369_muscle_phenotype | 2.50904969 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.46325384 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.39560735 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.36500738 |
| 23 | MP0005385_cardiovascular_system_phenoty | 2.30327893 |
| 24 | MP0001544_abnormal_cardiovascular_syste | 2.30327893 |
| 25 | MP0004484_altered_response_of | 2.24014922 |
| 26 | MP0006138_congestive_heart_failure | 2.07288064 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.81237873 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81106075 |
| 29 | MP0003828_pulmonary_edema | 1.80639645 |
| 30 | MP0004085_abnormal_heartbeat | 1.73391252 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.66397129 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.57121886 |
| 33 | MP0004510_myositis | 1.53386642 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.49339315 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.42344484 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.33900292 |
| 37 | MP0000733_abnormal_muscle_development | 1.25672453 |
| 38 | MP0005670_abnormal_white_adipose | 1.24223702 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.11192048 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.10457013 |
| 41 | MP0000343_altered_response_to | 1.07754801 |
| 42 | MP0000266_abnormal_heart_morphology | 1.02898604 |
| 43 | * MP0002108_abnormal_muscle_morphology | 1.00705065 |
| 44 | * MP0004233_abnormal_muscle_weight | 1.00202184 |
| 45 | MP0001661_extended_life_span | 1.00018093 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 0.99734135 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98491839 |
| 48 | MP0005266_abnormal_metabolism | 0.92871174 |
| 49 | MP0003279_aneurysm | 0.89848674 |
| 50 | MP0005165_increased_susceptibility_to | 0.86213998 |
| 51 | MP0002971_abnormal_brown_adipose | 0.83375516 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.78349974 |
| 53 | MP0010368_abnormal_lymphatic_system | 0.75621208 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 0.75529771 |
| 55 | MP0000013_abnormal_adipose_tissue | 0.72446438 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.70428189 |
| 57 | MP0010030_abnormal_orbit_morphology | 0.68871661 |
| 58 | MP0002128_abnormal_blood_circulation | 0.68686237 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.64349074 |
| 60 | MP0000372_irregular_coat_pigmentation | 0.63216538 |
| 61 | MP0005623_abnormal_meninges_morphology | 0.63094206 |
| 62 | MP0004043_abnormal_pH_regulation | 0.58501990 |
| 63 | MP0003566_abnormal_cell_adhesion | 0.56744430 |
| 64 | MP0004147_increased_porphyrin_level | 0.55082837 |
| 65 | MP0000767_abnormal_smooth_muscle | 0.54559688 |
| 66 | MP0008961_abnormal_basal_metabolism | 0.51808623 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.51705459 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.51139184 |
| 69 | MP0004134_abnormal_chest_morphology | 0.50986898 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.50751119 |
| 71 | MP0005275_abnormal_skin_tensile | 0.49591907 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 0.48031851 |
| 73 | MP0000762_abnormal_tongue_morphology | 0.47310997 |
| 74 | MP0003879_abnormal_hair_cell | 0.44622465 |
| 75 | MP0005451_abnormal_body_composition | 0.43632296 |
| 76 | MP0002114_abnormal_axial_skeleton | 0.41030347 |
| 77 | MP0005187_abnormal_penis_morphology | 0.40271421 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.39797016 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.38772484 |
| 80 | MP0005334_abnormal_fat_pad | 0.37934647 |
| 81 | MP0002925_abnormal_cardiovascular_devel | 0.37769449 |
| 82 | * MP0005319_abnormal_enzyme/_coenzyme | 0.36752607 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.36660592 |
| 84 | MP0009250_abnormal_appendicular_skeleto | 0.36322371 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 0.35584065 |
| 86 | MP0009384_cardiac_valve_regurgitation | 0.34656804 |
| 87 | MP0003948_abnormal_gas_homeostasis | 0.33650493 |
| 88 | MP0005535_abnormal_body_temperature | 0.31424530 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.30619381 |
| 90 | MP0004272_abnormal_basement_membrane | 0.30239372 |
| 91 | MP0001614_abnormal_blood_vessel | 0.29909678 |
| 92 | MP0009115_abnormal_fat_cell | 0.29231667 |
| 93 | MP0001542_abnormal_bone_strength | 0.29196488 |
| 94 | MP0005083_abnormal_biliary_tract | 0.29139065 |
| 95 | MP0001943_abnormal_respiration | 0.29081132 |
| 96 | MP0004142_abnormal_muscle_tone | 0.28777141 |
| 97 | MP0005166_decreased_susceptibility_to | 0.28406291 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.28240995 |
| 99 | MP0001784_abnormal_fluid_regulation | 0.27269407 |
| 100 | MP0008569_lethality_at_weaning | 0.26933161 |
| 101 | MP0003045_fibrosis | 0.26779089 |
| 102 | MP0004858_abnormal_nervous_system | 0.26471210 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.26452116 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.26030500 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.25167810 |
| 106 | MP0004270_analgesia | 0.24997434 |
| 107 | MP0001958_emphysema | 0.24656915 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.24555046 |
| 109 | MP0005452_abnormal_adipose_tissue | 0.24526515 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.23837118 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.23234717 |
| 112 | MP0003984_embryonic_growth_retardation | 0.22999453 |
| 113 | MP0002822_catalepsy | 0.22880936 |
| 114 | MP0003959_abnormal_lean_body | 0.22375250 |
| 115 | MP0003195_calcinosis | 0.22339210 |
| 116 | MP0002088_abnormal_embryonic_growth/wei | 0.21731749 |
| 117 | MP0009840_abnormal_foam_cell | 0.21112859 |
| 118 | MP0003011_delayed_dark_adaptation | 0.20792222 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.20177262 |
| 120 | MP0000249_abnormal_blood_vessel | 0.19348331 |
| 121 | MP0005332_abnormal_amino_acid | 0.18809706 |
| 122 | MP0009672_abnormal_birth_weight | 0.18697957 |
| 123 | MP0001853_heart_inflammation | 0.18643721 |
| 124 | MP0005595_abnormal_vascular_smooth | 0.18022743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.30982937 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.02359956 |
| 3 | Sudden death (HP:0001699) | 6.80171120 |
| 4 | Muscle fiber splitting (HP:0003555) | 6.26094551 |
| 5 | * Calf muscle hypertrophy (HP:0008981) | 5.85267389 |
| 6 | * Muscle hypertrophy of the lower extremities (HP:0008968) | 5.84316261 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.72426047 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.61345291 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.56218852 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.47243042 |
| 11 | Myoglobinuria (HP:0002913) | 5.34691771 |
| 12 | Subaortic stenosis (HP:0001682) | 4.97463344 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.97463344 |
| 14 | * Abnormality of the calf musculature (HP:0001430) | 4.94164256 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.76519109 |
| 16 | Difficulty running (HP:0009046) | 4.76465542 |
| 17 | Nemaline bodies (HP:0003798) | 4.75528729 |
| 18 | Atrial fibrillation (HP:0005110) | 4.71982738 |
| 19 | Increased connective tissue (HP:0009025) | 4.64029521 |
| 20 | Lipoatrophy (HP:0100578) | 4.50014724 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 4.41241608 |
| 22 | * EMG: myopathic abnormalities (HP:0003458) | 4.41084466 |
| 23 | Supraventricular tachycardia (HP:0004755) | 4.26390161 |
| 24 | Rhabdomyolysis (HP:0003201) | 4.25133520 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.17558387 |
| 26 | Myotonia (HP:0002486) | 4.05528427 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.99218585 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.97571622 |
| 29 | Bundle branch block (HP:0011710) | 3.86672001 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.84079621 |
| 31 | Popliteal pterygium (HP:0009756) | 3.76650004 |
| 32 | Fetal akinesia sequence (HP:0001989) | 3.74185995 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.62360864 |
| 34 | Palpitations (HP:0001962) | 3.61903992 |
| 35 | Syncope (HP:0001279) | 3.54596192 |
| 36 | Distal arthrogryposis (HP:0005684) | 3.53762257 |
| 37 | Muscle stiffness (HP:0003552) | 3.47394821 |
| 38 | Prolonged QT interval (HP:0001657) | 3.41722006 |
| 39 | Myopathic facies (HP:0002058) | 3.33969967 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.30311636 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.24538714 |
| 42 | Round ear (HP:0100830) | 3.23490932 |
| 43 | Heart block (HP:0012722) | 3.23391338 |
| 44 | Abnormal finger flexion creases (HP:0006143) | 3.22791770 |
| 45 | Ventricular arrhythmia (HP:0004308) | 3.21539944 |
| 46 | Neck muscle weakness (HP:0000467) | 3.08965091 |
| 47 | Abnormal atrioventricular conduction (HP:0005150) | 3.07601785 |
| 48 | Atrioventricular block (HP:0001678) | 3.02140784 |
| 49 | Type 2 muscle fiber atrophy (HP:0003554) | 3.01837829 |
| 50 | Areflexia of lower limbs (HP:0002522) | 3.00154686 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.95230914 |
| 52 | Abnormality of placental membranes (HP:0011409) | 2.81810640 |
| 53 | Amniotic constriction ring (HP:0009775) | 2.81810640 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.77091969 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.74795985 |
| 56 | Ulnar deviation of the wrist (HP:0003049) | 2.72910941 |
| 57 | Rimmed vacuoles (HP:0003805) | 2.67952112 |
| 58 | Abnormality of the calcaneus (HP:0008364) | 2.60506087 |
| 59 | Left ventricular hypertrophy (HP:0001712) | 2.49373361 |
| 60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.46512673 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45781443 |
| 62 | Abnormal EKG (HP:0003115) | 2.45418723 |
| 63 | Gowers sign (HP:0003391) | 2.45011318 |
| 64 | Hip contracture (HP:0003273) | 2.44953670 |
| 65 | Acute necrotizing encephalopathy (HP:0006965) | 2.42597887 |
| 66 | Distal lower limb amyotrophy (HP:0008944) | 2.40689995 |
| 67 | Hepatic necrosis (HP:0002605) | 2.40404034 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.38860064 |
| 69 | Testicular atrophy (HP:0000029) | 2.36820292 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.34978726 |
| 71 | Muscular dystrophy (HP:0003560) | 2.34359294 |
| 72 | Ketoacidosis (HP:0001993) | 2.30103388 |
| 73 | Slender build (HP:0001533) | 2.28518366 |
| 74 | Facial diplegia (HP:0001349) | 2.27324058 |
| 75 | Hypoplastic ischia (HP:0003175) | 2.26086869 |
| 76 | Frequent falls (HP:0002359) | 2.21352579 |
| 77 | Aplasia of the musculature (HP:0100854) | 2.19544598 |
| 78 | Calcaneovalgus deformity (HP:0001848) | 2.18813827 |
| 79 | Palmoplantar keratoderma (HP:0000982) | 2.17023718 |
| 80 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.16685719 |
| 81 | Abnormality of the neuromuscular junction (HP:0003398) | 2.14236446 |
| 82 | Fatigable weakness (HP:0003473) | 2.14236446 |
| 83 | Scapular winging (HP:0003691) | 2.12675367 |
| 84 | Hepatocellular necrosis (HP:0001404) | 2.12374391 |
| 85 | Increased muscle lipid content (HP:0009058) | 2.12158096 |
| 86 | Malignant hyperthermia (HP:0002047) | 2.12032168 |
| 87 | Absent phalangeal crease (HP:0006109) | 2.09154040 |
| 88 | Acute encephalopathy (HP:0006846) | 2.08843753 |
| 89 | Easy fatigability (HP:0003388) | 2.07002673 |
| 90 | Proximal amyotrophy (HP:0007126) | 2.06801844 |
| 91 | Waddling gait (HP:0002515) | 2.05011275 |
| 92 | Exercise intolerance (HP:0003546) | 2.03793122 |
| 93 | Hyperkalemia (HP:0002153) | 2.02263184 |
| 94 | Abnormality of the foot musculature (HP:0001436) | 2.01289564 |
| 95 | Progressive macrocephaly (HP:0004481) | 1.98915342 |
| 96 | Weak cry (HP:0001612) | 1.98377912 |
| 97 | Bulbar palsy (HP:0001283) | 1.98341517 |
| 98 | Deformed tarsal bones (HP:0008119) | 1.97580423 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.97562150 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97244867 |
| 101 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96940345 |
| 102 | Mitochondrial inheritance (HP:0001427) | 1.96821588 |
| 103 | Progressive muscle weakness (HP:0003323) | 1.96496524 |
| 104 | Abnormality of the ischium (HP:0003174) | 1.96449855 |
| 105 | Nonprogressive disorder (HP:0003680) | 1.96389689 |
| 106 | Hypoglycemic coma (HP:0001325) | 1.92842834 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89974723 |
| 108 | Metatarsus adductus (HP:0001840) | 1.89375382 |
| 109 | Spinal rigidity (HP:0003306) | 1.89327064 |
| 110 | Cerebral edema (HP:0002181) | 1.88106573 |
| 111 | Conjunctival hamartoma (HP:0100780) | 1.87804859 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85858840 |
| 113 | Long clavicles (HP:0000890) | 1.85376354 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.84473821 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84473821 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.84407778 |
| 117 | Increased CSF lactate (HP:0002490) | 1.84300551 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82607808 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.78908334 |
| 120 | Thin ribs (HP:0000883) | 1.76426228 |
| 121 | Limited hip movement (HP:0008800) | 1.68962149 |
| 122 | Pterygium (HP:0001059) | 1.66324240 |
| 123 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.59475360 |
| 124 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.59475360 |
| 125 | Ulnar deviation of finger (HP:0009465) | 1.51018632 |
| 126 | Hypoplastic heart (HP:0001961) | 1.47212618 |
| 127 | Steppage gait (HP:0003376) | 1.46320592 |
| 128 | Akinesia (HP:0002304) | 1.45994965 |
| 129 | Generalized amyotrophy (HP:0003700) | 1.45796296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.77818814 |
| 2 | OBSCN | 5.74336234 |
| 3 | PHKG2 | 4.71186466 |
| 4 | PHKG1 | 4.71186466 |
| 5 | PDK4 | 3.26130215 |
| 6 | PDK3 | 3.26130215 |
| 7 | DMPK | 2.90558544 |
| 8 | MYLK | 2.87962584 |
| 9 | LMTK2 | 2.84962887 |
| 10 | TRIB3 | 2.68170501 |
| 11 | MUSK | 2.65982145 |
| 12 | BCKDK | 2.44513024 |
| 13 | PKN2 | 2.30520798 |
| 14 | PINK1 | 2.25637721 |
| 15 | NEK1 | 2.25601088 |
| 16 | PIK3CA | 2.17042812 |
| 17 | PDK2 | 2.01176556 |
| 18 | MOS | 1.67733223 |
| 19 | NME1 | 1.61351394 |
| 20 | MAP2K3 | 1.58555502 |
| 21 | PIK3CG | 1.48536619 |
| 22 | TIE1 | 1.47227358 |
| 23 | STK24 | 1.40693133 |
| 24 | MAP3K7 | 1.36711750 |
| 25 | LIMK1 | 1.31218800 |
| 26 | MAPK12 | 1.27094715 |
| 27 | MARK1 | 1.16557109 |
| 28 | PAK3 | 1.08238243 |
| 29 | PRKD1 | 1.05105064 |
| 30 | CCNB1 | 1.02209649 |
| 31 | ILK | 1.01093031 |
| 32 | GRK7 | 0.99421743 |
| 33 | CAMK2D | 0.97811399 |
| 34 | MAPKAPK3 | 0.97547004 |
| 35 | PRKAA1 | 0.90227372 |
| 36 | ZAK | 0.88927540 |
| 37 | ROCK1 | 0.86454241 |
| 38 | PRKAA2 | 0.84656446 |
| 39 | TRPM7 | 0.79854620 |
| 40 | RIPK1 | 0.78788093 |
| 41 | MAP3K3 | 0.76821845 |
| 42 | MAP3K5 | 0.76339443 |
| 43 | DYRK1B | 0.75087047 |
| 44 | PKN1 | 0.71952766 |
| 45 | MAP3K13 | 0.68184699 |
| 46 | CDC42BPA | 0.67919954 |
| 47 | STK38L | 0.66702799 |
| 48 | EPHB1 | 0.65795115 |
| 49 | STK4 | 0.61426340 |
| 50 | INSRR | 0.58654041 |
| 51 | PDGFRA | 0.58208874 |
| 52 | ERBB3 | 0.56833949 |
| 53 | WNK4 | 0.56454878 |
| 54 | ICK | 0.55958723 |
| 55 | MAP2K6 | 0.54663028 |
| 56 | MAP2K4 | 0.53826971 |
| 57 | DAPK3 | 0.53545849 |
| 58 | FLT3 | 0.53487043 |
| 59 | NEK9 | 0.53475944 |
| 60 | MAPK4 | 0.52498263 |
| 61 | ROCK2 | 0.51582252 |
| 62 | STK38 | 0.49357519 |
| 63 | CAMK4 | 0.47533508 |
| 64 | PRKACB | 0.47098538 |
| 65 | AKT2 | 0.45981447 |
| 66 | KSR2 | 0.45872118 |
| 67 | TGFBR2 | 0.45613814 |
| 68 | CAMK2G | 0.43634224 |
| 69 | CAMK2B | 0.43340557 |
| 70 | CAMK2A | 0.43042178 |
| 71 | PTK2B | 0.41685920 |
| 72 | RPS6KL1 | 0.40544269 |
| 73 | RPS6KC1 | 0.40544269 |
| 74 | SIK1 | 0.38223414 |
| 75 | WNK1 | 0.37246326 |
| 76 | PRKACA | 0.34280140 |
| 77 | RPS6KA6 | 0.33703245 |
| 78 | PDPK1 | 0.32886466 |
| 79 | PTK6 | 0.32471876 |
| 80 | PRKD3 | 0.31902465 |
| 81 | ARAF | 0.30530442 |
| 82 | KDR | 0.30489027 |
| 83 | CAMK1 | 0.28850325 |
| 84 | PRKACG | 0.28845825 |
| 85 | MAPK11 | 0.26998716 |
| 86 | TAOK1 | 0.26366229 |
| 87 | PDK1 | 0.25039852 |
| 88 | SGK2 | 0.25021740 |
| 89 | MAPK10 | 0.24541730 |
| 90 | PRKCE | 0.23482390 |
| 91 | MAPK13 | 0.22098648 |
| 92 | RPS6KA1 | 0.21679258 |
| 93 | PRKG1 | 0.21477329 |
| 94 | CDK19 | 0.21110055 |
| 95 | MTOR | 0.20859878 |
| 96 | SGK1 | 0.20718247 |
| 97 | PRKCH | 0.20221756 |
| 98 | RPS6KB1 | 0.20097777 |
| 99 | MARK2 | 0.20020266 |
| 100 | TBK1 | 0.19426786 |
| 101 | MAP3K6 | 0.19186825 |
| 102 | MAP3K11 | 0.19045452 |
| 103 | RPS6KA3 | 0.18980273 |
| 104 | RPS6KB2 | 0.17327135 |
| 105 | SGK3 | 0.16624834 |
| 106 | LATS2 | 0.16580729 |
| 107 | NME2 | 0.15673408 |
| 108 | EPHA3 | 0.15564495 |
| 109 | MAP3K1 | 0.15513417 |
| 110 | MAPK7 | 0.14979531 |
| 111 | EEF2K | 0.14781650 |
| 112 | MAP3K10 | 0.13763912 |
| 113 | EPHB2 | 0.13376989 |
| 114 | FER | 0.12547067 |
| 115 | TAOK2 | 0.12296466 |
| 116 | PAK6 | 0.11951950 |
| 117 | MAP2K1 | 0.11887489 |
| 118 | RPS6KA2 | 0.11839889 |
| 119 | LRRK2 | 0.11819656 |
| 120 | DDR2 | 0.11418397 |
| 121 | LATS1 | 0.10913035 |
| 122 | RET | 0.10733223 |
| 123 | STK39 | 0.10639939 |
| 124 | JAK1 | 0.10303115 |
| 125 | DAPK2 | 0.10289477 |
| 126 | SGK494 | 0.08237554 |
| 127 | SGK223 | 0.08237554 |
| 128 | PRPF4B | 0.07356426 |
| 129 | RAF1 | 0.06394253 |
| 130 | BRAF | 0.05173968 |
| 131 | PRKG2 | 0.04806863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.71248334 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.39330599 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.22612497 |
| 4 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.80792600 |
| 5 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.74428807 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30479098 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.18671568 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.02800331 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.90649726 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64576749 |
| 11 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.59367978 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.47801513 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30808187 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13676054 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13529869 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99572768 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.82990176 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.80221447 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79804390 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44763962 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40622418 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38857280 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.32097364 |
| 24 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.31999875 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.28121440 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20721696 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19337565 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19112845 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18893728 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06704434 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02597508 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01413030 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96099149 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94232042 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91727863 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91392212 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90777348 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.83263989 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80911054 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80248865 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74561361 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73847040 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71895759 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71265813 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.70853368 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69727342 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68667087 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67348557 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67184583 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66364556 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66324267 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64106569 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.63134079 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62277437 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61610472 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59038182 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58020043 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55678447 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.51639119 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49818666 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.48773795 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48636070 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48608025 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46884660 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44821935 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42892527 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.41712997 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40905436 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.38172858 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37674965 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35783632 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.35641467 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.34958330 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32031145 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29033582 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28056777 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.27133711 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26818815 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.25925438 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25084733 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24458264 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.23774175 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.23390919 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.23322979 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23066449 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22834285 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22434727 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22180104 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21797541 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20552071 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19287907 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.19197792 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19044043 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18308749 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18050157 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16395335 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16365500 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14536606 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13535241 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13455408 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.13289779 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10880623 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.10826784 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.10709211 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08797053 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.07897750 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.07409281 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07218004 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06373835 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03963139 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.03429714 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03053751 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.01628876 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01590941 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0426722 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0417757 |

